"What had sparked some excitement came in light of new analyst activity. Oppenheimer analyst Leland Gershell initiated coverage on . The analyst gave it an Outperform rating and announced a price target of $5. That represents a 182% premium to Friday’s closing price for stock."
Original Quote Source: 5 Biotech Penny Stocks To Watch With Recent & Upcoming Events